This is in line with studies that report CXCL12/CXCR4 signaling improves cognitive performance in other models of brain disease (Capsoni et al., 2017; Trousse et al., 2019), suggesting our results may also inform CNS therapeutic strategies more broadly. The gene discussed is CXCR4; the disease is brain disorder.